Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2010
12/08/2010EP2258366A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
12/08/2010EP2257531A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors
12/08/2010EP2257527A1 Substituted sulfonamide derivatives
12/08/2010EP1891011B1 Tetrahydroquinolines used in the form of modulators of mitotic motor-proteins eg5
12/08/2010EP1434813B1 Polymers , their synthesis, and electronic devices incorporating same
12/08/2010CN1930105B Method for preparation of a fluoroaromatic compound from an aminoaromatic amine compound
12/08/2010CN1929840B 8-hydroxy-5- [(-hydroxy-2- [[ (1R)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation
12/08/2010CN1715363B Iridium (III) complex with heteroatom linking group and organic electroluminescent device using the same
12/08/2010CN101910135A Quinoline derivatives and their use as fungicides
12/08/2010CN101906076A Naphthaline amide derivative serving as protein kinase inhibitor and histone deacetylase inhibitor and preparation method and application thereof
12/08/2010CN101906072A 3-phenylquinoline compounds as well as preparation method and application thereof
12/08/2010CN101906053A 酰胺衍生物 Amide derivatives
12/08/2010CN101481350B Process for synthesizing norfloxacin
12/08/2010CN101212971B 4-phenyl-5-0x0-l,4,5,6,7,8-hexahydr0quin0line derivatives as medicaments for the treatment of infertility
12/07/2010US7847125 additives for stabilizing organic products that are subject to oxidative, thermal, and/or light-induced degradation and in need of stabilization to prevent or inhibit such degradation, e.g., additives for lubricating oils that can improve the antioxidant properties of the oil
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010CA2499335C Method for producing a 3,5-dihydroxy-6-heptenoate
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137032A2 Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts
12/02/2010US20100305326 Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage
12/02/2010US20100305320 Polymorph, polymorph screening system, and polymorph preparing and screening method
12/02/2010US20100305154 Prolyl Hydroxylase Inhibitors
12/02/2010US20100305107 Quinoline derivatives and their use as 5-ht6 ligands
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305080 Novel Crystalline Salts of Montelukast
12/02/2010US20100304966 Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same
12/02/2010US20100303899 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/01/2010EP2256119A1 Vasopressin V1a antagonists
12/01/2010EP2254860A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor
12/01/2010EP2254666A1 2-aminoquinolines as 5-ht5a receptor antagonists
12/01/2010CN1852713B Polymorphic form of montelukast sodium
12/01/2010CN101903335A Amine linked modulators of gamma-secretase
12/01/2010CN101899003A Quinoline derivative-N-oxide ligand as well as preparation method and application thereof
12/01/2010CN101899002A Method for preparing oxine copper, and product of oxine copper
12/01/2010CN101898982A Npy y5 antagonists
12/01/2010CN101898925A Green synthesis and industrialization method of chloro-substituted heterocyclic ring
12/01/2010CN101367762B Preparation method of midbody 7-chloroquinaldine
12/01/2010CN101151345B Organic EL material, organic EL element employing the same, and process for producing organic EL element
11/2010
11/30/2010US7842835 Increasing sensitivity of cancer cells to radiotherapy cytotoxic effects; neurological diseases; such as n-hydroxy-4-[3-(2-hydroxy-2-phenyl-ethyl)-ureido]-butyramide
11/30/2010US7842811 Have negatively charged substituent for fluorescent staining of DNA; used to distinguish DNA present in a sample from RNA
11/30/2010US7842810 2,3-Dihydro-benzo[1,4]dioxine-6-carboxylic acid [2-(6-methoxy-quinolin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-yl]-amide
11/30/2010CA2477208C Substituted phenylalkanoic acid derivatives and use thereof
11/30/2010CA2450076C Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
11/25/2010WO2010133748A1 Protease inhibitors
11/25/2010WO2010133672A1 Derivatives of quinoline-3-carboxylic acid and their medical use
11/25/2010WO2010133669A1 Substituted quinolines for use as vegf inhibitors
11/25/2010US20100298374 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010US20100298356 Saturated and insaturated bi- or tricyclic aryloxyacetamine derivatives and their use as fungicides
11/25/2010US20100298209 Compounds for preventing or treating a viral infection
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010US20100297016 Quarternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
11/25/2010CA2762427A1 Nitrile derivatives and their pharmaceutical use and compositions
11/25/2010CA2762232A1 Substituted quinolines for use as vegf inhibitors
11/25/2010CA2758222A1 Protease inhibitors
11/24/2010EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
11/24/2010EP2253619A1 Amine salt of carbostyril derivative
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252605A2 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
11/24/2010EP2252372A1 2-aminoquinolines
11/24/2010EP2252299A1 Fused pyridone m1 receptor positive allosteric modulators
11/24/2010EP1583972B1 Methods for identifying drug non-target proteins
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN101891680A Modulators of atp-binding cassette transporters
11/24/2010CN101891627A Ruthenium-containing coordination compound and preparation method thereof
11/23/2010CA2584789C Method for the preparation of aripiprazole, and corresponding intermediates and their preparation
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/23/2010CA2377309C Compounds for the modulation of ppar.gamma. activity
11/23/2010CA2342200C Use of certain drugs for treating nerve root injury
11/18/2010WO2010132029A1 Octahydro biquinoline compound
11/18/2010WO2010131054A1 Redox drug derivatives
11/18/2010WO2010077798A3 Stereoselective synthesis of piperidine derivatives
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292480 Process and intermediates for preparing integrase inhibitors
11/18/2010US20100292271 Quinoline Compounds Suitable for Treating Disorders that Respond to Modulation of the Serotonin-5-HT6 Receptor
11/18/2010US20100292251 Montelukast benzhydryl piperazine salts and process for preparation thereof
11/18/2010US20100292241 3,5-substituted-1,3-oxazolidin-2-one derivatives
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/18/2010US20100292215 11beta-hydroxysteroid dehydrogenase type 1 active compounds
11/18/2010CA2762022A1 Redox drug derivatives
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme
11/17/2010EP2250152A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase
11/17/2010EP2250151A1 Compounds having electroluminescent or electron transport properties
11/17/2010EP1032377B1 Substituted 2-aminoacetamides and the use thereof
11/17/2010CN101885704A Electron transport material and organic electroluminescence device thereof
11/17/2010CN101885653A Synthesis method of N-heteroaryl amino acid
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834047 Arylsulfonamides and uses related thereto
11/16/2010US7834044 Substituted-2-imidazoles
11/16/2010US7834029 For therapy of cancer; treating prostate cancer with 2-(6-methyl-pyridin-2-yl)-3-[6-amido-quinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole; TGF-beta signal transduction inhibitors
11/16/2010US7834016 breast cancer, prostate cancer, and colon cancer; indole, indoline, indol-2-one, or benzimidazoline based compounds having arylamine groups, for example 1-(pyrid-4-ylamino)-4-(2-(indol-3-yl)ethylamino)benzene
11/16/2010CA2487329C Process for the manufacture of quinoline derivatives
11/11/2010WO2010129467A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010WO2010129451A1 Process for preparing bromo-substituted quinolines
11/11/2010WO2010128345A1 Kynurenic acid analogues, pharmaceutical compositions containing same and use of said compounds for the treatment of headache
11/11/2010WO2010127608A1 Heterocyclic substituted acardite derivates and use thereof
11/11/2010WO2010127452A1 5-oxo-ete receptor antagonist compounds
11/11/2010WO2009143178A3 Pde10 inhibitors and related compositions and methods
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 277